These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 4195441

  • 21. Liver function during amantadine hydrochloride medication in compensated liver disease.
    Schnack H, Wewalka F, Guttmann G.
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):185-7. PubMed ID: 5800713
    [No Abstract] [Full Text] [Related]

  • 22. [Immunosuppressive treatment of chronic hepatitis].
    Magyar I.
    Dtsch Z Verdau Stoffwechselkr; 1970 Apr; 30(1):31-4. PubMed ID: 5501423
    [No Abstract] [Full Text] [Related]

  • 23. Normotest in acute hepatitis and chronic liver disease.
    Ockerman PA, Braconier JH, Eriksson O.
    Scand J Gastroenterol Suppl; 1973 Apr; 19():83-91. PubMed ID: 4515643
    [No Abstract] [Full Text] [Related]

  • 24. Primary biliary cirrhosis: a description of four cases.
    Chong RS, Ng HS, Seah CS.
    Singapore Med J; 1988 Feb; 29(1):68-71. PubMed ID: 3406774
    [No Abstract] [Full Text] [Related]

  • 25. [The treatment of primary biliary liver cirrhosis with rifampicin].
    Loginov AS, Reshetniak VI, Petrakov AV.
    Ter Arkh; 1993 Feb; 65(8):57-62. PubMed ID: 8211805
    [Abstract] [Full Text] [Related]

  • 26. [Contribution on the therapy of chronic liver parenchymal damage with 6-mercaptopurine].
    Mott R, Knief J, Faul J.
    Med Klin; 1968 Sep 06; 63(36):1422-8. PubMed ID: 5729432
    [No Abstract] [Full Text] [Related]

  • 27. Effect of bezafibrate in primary biliary cirrhosis: a pilot study.
    Ohmoto K, Mitsui Y, Yamamoto S.
    Liver; 2001 Jun 06; 21(3):223-4. PubMed ID: 11422787
    [No Abstract] [Full Text] [Related]

  • 28. [Attempted classification, course and elements of prognosis of chronic hepatitis. Preliminary results of a study of 100 cases].
    Thomas M, Rosner D, Nusinovici V, Caroli J.
    Ann Med Interne (Paris); 1972 Feb 06; 123(2):107-17. PubMed ID: 4115527
    [No Abstract] [Full Text] [Related]

  • 29. Azathioprine in primary biliary cirrhosis: a preliminary report of an international trial.
    Crowe J, Christensen E, Smith M, Cochrane M, Ranek L, Watkinson G, Doniach D, Popper H, Tygstrup N, Williams R.
    Gastroenterology; 1980 May 06; 78(5 Pt 1):1005-10. PubMed ID: 6991353
    [Abstract] [Full Text] [Related]

  • 30. The activity of serum ornithine-carbamyl transferase in patients with liver cirrhosis.
    Ignatowska-Switalska H, Wasowska-Ciszek T.
    Pol Med J; 1969 May 06; 8(1):57-61. PubMed ID: 5782170
    [No Abstract] [Full Text] [Related]

  • 31. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
    Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB, Houben MH, Witteman BJ, van Erpecum KJ, van Buuren HR, Dutch PBC Study Group.
    Gastroenterology; 2009 Apr 06; 136(4):1281-7. PubMed ID: 19208346
    [Abstract] [Full Text] [Related]

  • 32. [Biological surveillance during a test of 804 CB in internal medicine. 120 observations].
    Gallais H, Casanova P.
    Arzneimittelforschung; 1974 Sep 06; 24(9A SUPPL):1442-4. PubMed ID: 4480073
    [No Abstract] [Full Text] [Related]

  • 33. [The prognostic value of serochemical cholestasis parameters in liver cirrhosis].
    Rink C, Haerting J, Nilius R.
    Z Gastroenterol; 1993 Feb 06; 31 Suppl 2():67-70. PubMed ID: 7483719
    [Abstract] [Full Text] [Related]

  • 34. [The treatment of inflammatory liver diseases with 6-mercaptopurine (6-MP)].
    Weinreich J.
    Acta Hepatosplenol; 1967 Feb 06; 14(4):189-98. PubMed ID: 5589685
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical significance of direct bilirubin of delayed reaction].
    Teijeira J, Alves J, Santolaria F, Cabarcos A, Huguet R, Bruguera JA, Liso P.
    Rev Esp Enferm Apar Dig; 1975 Jan 06; 45(1):13-22. PubMed ID: 1118650
    [No Abstract] [Full Text] [Related]

  • 36. Cellular sensitivity to native type IV collagen in primary biliary cirrhosis.
    Suou T, Ago H, Sawada H, Hirayama C.
    Res Commun Chem Pathol Pharmacol; 1993 Mar 06; 79(3):275-91. PubMed ID: 8480075
    [Abstract] [Full Text] [Related]

  • 37. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
    Rühl R, Seidensticker M, Peters N, Mohnike K, Bornschein J, Schütte K, Amthauer H, Malfertheiner P, Pech M, Ricke J.
    Dig Dis; 2009 Mar 06; 27(2):189-99. PubMed ID: 19546558
    [Abstract] [Full Text] [Related]

  • 38. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
    Chan CW, Gunsar F, Feudjo M, Rigamonti C, Vlachogiannakos J, Carpenter JR, Burroughs AK.
    Aliment Pharmacol Ther; 2005 Feb 01; 21(3):217-26. PubMed ID: 15691295
    [Abstract] [Full Text] [Related]

  • 39. [Ursodeoxycholic acid therapy in biliary cirrhosis].
    Herszényi L, Szalay L, Schaff Z, Gergely P, Fehér J.
    Orv Hetil; 1993 Sep 19; 134(38):2085-9. PubMed ID: 8414454
    [Abstract] [Full Text] [Related]

  • 40. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
    Wolfhagen FH, van Buuren HR, Schalm SW.
    Neth J Med; 1994 Mar 19; 44(3):84-90. PubMed ID: 8202208
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.